Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Restatement
confidence 98%
filed 2026-06-23
The filing discloses under Item 4.02 that the Board concluded on June 23, 2026 that previously issued unaudited condensed consolidated financial statements for three interim periods in 2024 (Q1, Q2, and Q3) should no longer be relied upon due to multiple accounting errors including misclassifications of client funds, related party advances, subscription receivables, intercompany eliminations, omitted share issuances, and foreign currency translation errors. The Company identified material weaknesses in internal controls and restated the affected interim periods as comparative information in amended 2025 quarterly reports. This is a clear financial restatement disclosure under Item 4.02.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-23
Wayne Tupuola, the President and CEO, took a three-month leave of absence for health reasons on June 16, 2026, and the Board appointed Ann Tewari, Executive Vice President of Global Operations and Strategy, as Interim President. While the filing discloses both a departure (Tupuola's leave) and an appointment (Tewari's interim role), the principal disclosed action centers on the appointment of interim leadership to fill the CEO vacancy during Tupuola's absence. This is material as it affects the registrant's executive leadership structure and investor assessment of operational continuity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The filing discloses an unregistered sale of 356 Series A Convertible Preferred Shares to TriCore Foundation, LLC for $320,400 on June 17, 2026, made in reliance on Section 4(a)(2) of the Securities Act. This is a classic dilutive issuance under Item 3.02, involving convertible securities sold to a related party without registration. The transaction is material as it represents new equity capital raised and potential dilution to existing shareholders upon conversion.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-23
The Company entered into a Loan and Security Agreement on June 18, 2026, creating a new $2.5 million secured term loan obligation with a 10% interest rate maturing June 17, 2027. This is a material creation of direct financial obligation. The Company explicitly states it intends to use proceeds to repay an existing credit facility, indicating this is a refinancing event. The security interest granted in all assets and restrictive covenants (restrictions on incurring additional indebtedness, liens, and business changes) are typical debt issuance terms.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-23
The filing discloses entry into a definitive Agreement and Plan of Merger (Item 1.01) whereby Black Pearl Equities will acquire all outstanding shares of Selectis Health for $5.75 per share in cash through a tender offer followed by a short-form merger. This is a material acquisition transaction with clear economic terms, board approval, and no financing contingencies, representing a change of control of the company.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-06-23
The filing discloses that on June 23, 2026, the Audit Committee dismissed BCRG as the independent registered public accounting firm and appointed Simon & Edward LLP as the new auditor, effective after BCRG's attest business was acquired by S&E on June 15, 2026. This is a clear auditor change under Item 4.01. The materiality is heightened by the disclosure that BCRG's prior audit reports contained an explanatory paragraph indicating substantial doubt about the Company's ability to continue as a going concern.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-23
The Board authorized engagement of specialized litigation counsel to pursue legal remedies against former management and service providers for alleged self-dealing, unauthorized dilutive equity issuances, and improper debt instruments. The disclosure explicitly identifies allegations of misconduct, directs counsel to prepare formal demands for restitution and potential court complaints, and seeks recovery of assets and cancellation of securities—hallmarks of material litigation activity that would affect investor assessment of the company's governance and financial position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
Item 5.02
Robert Brackenbury was appointed to the Board of Directors of Athene Holding Ltd. as an independent director effective June 23, 2026. Brackenbury brings extensive experience as Deputy Chief Investment Officer of the State of Michigan Retirement System, where he oversaw $170 billion in assets, and brings expertise in retirement services and institutional investment management.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-23
Item 8.01
The Company engaged CBRE's National Retail Partners on June 19, 2026 to "list and market for sale thirty-five of those fifty-nine properties as a portfolio sale transaction." This represents a material disposition of approximately 59% of the Company's real estate portfolio. Although the transaction is contemplated rather than completed, the engagement of a major broker to market a substantial portfolio for sale constitutes a material M&A/disposition activity that would affect a reasonable investor's assessment of the registrant's strategic direction and asset base.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
Item 5.02
The filing discloses the appointment of Ron Philip to the Board of Directors of Avalo Therapeutics, effective June 23, 2026. The principal disclosed action is a person taking a role as director and committee member. While the disclosure includes compensatory arrangements (stock option grant of 40,200 shares), the core event is the appointment itself, making exec_appointment the most salient classification. Board appointments by experienced executives (Philip's background includes CEO roles at Spark Therapeutics and Orbital Therapeutics) are material to investors.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-06-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-1." This is a distribution to certificate holders of a structured trust, which constitutes a dividend or distribution event. The materiality is supported by the fact that the trust is disclosing this distribution activity to the market, and distributions to security holders are typically material to investors.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-06-23
Item 8.01
The filing explicitly states it "relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-2." This is a distribution to security holders of a structured trust vehicle. While the disclosure is largely boilerplate regarding underlying issuer reporting requirements, the core event triggering the 8-K is the distribution itself, which falls under dividend_distribution. The materiality is marked true because distributions to certificate holders are material to investors in the trust.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-06-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-3." This is a distribution to certificate holders, which constitutes a dividend or distribution event. While the prose is largely boilerplate disclosure about underlying security issuers and SEC reporting requirements, the core event disclosed is the distribution itself, making this a dividend_distribution classification.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-06-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-4." This is a distribution to certificate holders, which constitutes a dividend or distribution event. While the disclosure is largely boilerplate regarding underlying security reporting requirements, the core event triggering the 8-K is the distribution itself, making this a dividend_distribution classification.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-06-23
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-5." This is a distribution to certificate holders, which constitutes a dividend or distribution event. While the disclosure is largely boilerplate regarding underlying security reporting requirements, the core event disclosed is the distribution itself, making this a dividend_distribution classification.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-23
This 8-K discloses the entry into an underwriting agreement for the issuance of mortgage pass-through certificates (Series 2026-5C10) with an aggregate initial principal amount of $475.2 million in publicly offered certificates plus $71 million in privately offered certificates. The filing describes the creation of a new direct financial obligation through the issuance of debt securities backed by a pool of commercial mortgage loans, which is the hallmark of a debt issuance event under Item 8.01 (Other Events).
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-23
EX-99.1
Trinity Biotech announced the launch of Trinovium, a new subsidiary focused on advanced liquid cooling solutions for AI data centers. This represents a material strategic expansion into a new market segment (projected to grow from $4 billion in 2026 to $27 billion by 2033) leveraging existing manufacturing capacity. While not a traditional M&A transaction, the creation of a dedicated subsidiary with a distinct business focus and capital-efficient entry into a high-growth market constitutes a significant operational and strategic initiative that would affect a reasonable investor's assessment of the company's growth prospects and business diversification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
Item 5.02
Cal-Maine Foods appointed two independent directors, Haley R. Fisackerly and Michael J. Highfield, to its Board of Directors effective June 23, 2026, expanding the Board from eight to ten directors. The new directors bring expertise in operations, infrastructure, finance, capital markets, and organizational leadership, and were assigned to three Board committees.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-06-23
Item 8.01
News Corporation discloses daily buy-back notifications under its US$1 billion repurchase program authorized as of July 15, 2025. The Item 8.01 disclosure reports that the Company has purchased approximately US$323.8 million worth of Class A and Class B shares to date, with recent transactions totaling US$210 million across both classes. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution taxonomy as a return of capital, distinct from operational or financial events. The materiality is evident from the scale (US$1 billion authorization, US$323.8 million deployed) and the explicit statement that the repurchase is intended "to enhance shareholder value."
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-23
Item 1.01
AMASS Brands invested $1,535,000 (after amendment) in AfterDream via a SAFE agreement, which is a form of convertible equity instrument that will convert into shares upon future triggering events (Equity Financing, Liquidity Event, or Dissolution Event). While the SAFE is technically an investment by AMASS rather than an issuance by AMASS, the structure and mechanics—conversion into equity at a valuation cap with dilutive potential—align with the dilutive_issuance category's focus on equity capital raises. However, this could also be classified as a material investment or financial transaction under financial_other if viewed as AMASS deploying capital rather than raising it. The Item 1.01 designation and the material dollar amount ($1.535M) support materiality.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 1.01
Upwork entered into a $150 million secured revolving credit facility with Bank of America as administrative agent on June 23, 2026, with an option to increase by up to $50 million. The facility has customary covenants, interest rate terms, and a three-year maturity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-23
Item 2.02
Sunbelt Rentals disclosed financial results for fiscal fourth quarter and full-year ended April 30, 2026, including total revenue of $11.154 billion, net income of $1.325 billion, and adjusted EBITDA of $4.677 billion, along with forward guidance for fiscal 2027 and capital allocation decisions totaling $1.877 billion in dividends and buybacks.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-23
Item 1.01
Backblaze entered into a Master Strategic Agreement with CoreWeave effective June 16, 2026, representing a material multi-year commercial arrangement valued at approximately $335 million over five to seven years. The agreement establishes a significant strategic partnership for HDD-based storage capacity supporting CoreWeave's AI infrastructure and includes equity consideration through warrant issuance of 4.2 million shares.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This 8-K Item 5.07 discloses the final voting results from GeneDx Holdings Corp.'s Annual Meeting of Stockholders held on June 18, 2026. The filing presents detailed tabulations of votes cast on four proposals: election of a Class II director (Katherine Stueland), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals were approved. This is a standard shareholder vote results disclosure required under Item 5.07.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-23
EX-99.1
This exhibit discloses the results of Klarna Group plc's 2026 Annual General Meeting held on 22 June 2026, with detailed voting tallies for all 12 resolutions including re-appointment of directors (Niclas Neglén, Andrew Reed, Mateusz Staniszewski, Markus Villig), re-appointment of auditors (Ernst & Young LLP), and approval of remuneration policies. All resolutions passed at or above 99% of votes cast, representing shareholder governance decisions that are material to investors' assessment of board composition and auditor continuity.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-06-23
EX-99.1
This is a quarterly earnings press release disclosing ICON's Q1 2026 financial results, including revenue of $2,034.0 million, GAAP net income of $104.8 million ($1.36 diluted EPS), adjusted EBITDA of $317.7 million, and reaffirmed full-year 2026 guidance. The document contains consolidated statements of operations, balance sheets, and cash flows for the three months ended March 31, 2026, along with management commentary from CEO Barry Balfe. This is a material event affecting investor assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-23
Item 3.02
The Fund sold 341,423 Class I common shares for $9.2 million during June 2026 in an unregistered offering exempt under Section 4(a)(2) and Regulation S, materially diluting existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-06-23
Item 8.01
The Fund declared and paid regular monthly distributions to shareholders across multiple share classes (Class I, S, and D) for June 2026 and forward months (July, August, September 2026) at specified per-share amounts and payment dates.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-23
Item 2.02
This is a clear earnings release disclosing Q1 2026 financial results for Cerebras Systems. The Item 2.02 section explicitly states "On June 23, 2026, Cerebras Systems Inc. announced its financial results for the quarter ended March 31, 2026" with the full press release furnished as Exhibit 99.1. The press release reports GAAP revenue of $193.4 million (up 94% YoY), core revenue of $191.3 million (up 92% YoY), and provides forward guidance for Q2 and full-year 2026. This is material to investors as it discloses the company's quarterly operating performance and future outlook.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-06-23
Item 8.01
SpaceX announced the pricing and commencement of a $25 billion inaugural bond offering across five tranches of senior unsecured notes due 2031–2056, with settlement expected June 26, 2026. This is a material creation of direct financial obligations. The company intends to use proceeds to repay bridge loan borrowings and for general corporate purposes, representing a significant capital-raising event typical of debt_issuance disclosures under Item 2.03 or Item 8.01.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-23
Item 5.02
Adriano Duarte was appointed Executive Vice President and Chief Financial Officer of Provident Financial Services, Inc. and Provident Bank, effective July 1, 2026. Duarte brings over 30 years of banking experience and previously served as Chief Accounting Officer, and will report directly to the CEO and serve on the Executive Leadership Team.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-23
EX-99.1
Ferrari announces the appointment of Massimiliano Di Silvestre as Chief Marketing & Commercial Officer effective July 1, 2026, joining the Leadership Team and reporting to CEO Benedetto Vigna. While the announcement also mentions Enrico Galliera's departure after sixteen years, the principal disclosed action is the appointment of a named executive to a C-suite role. This is material as it affects the composition of Ferrari's senior leadership and the company's strategic direction in marketing and commercial operations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-23
Item 5.02
The filing discloses the appointment of Moncef Slaoui to the Board as a Class II director effective immediately on June 17, 2026, upon recommendation of the Nominating and Corporate Governance Committee. While the section also mentions Jacks Lee's retirement from the Board and his entry into a consulting agreement, the principal disclosed action centers on the new director appointment. Board composition changes are material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-23
Item 7.01
This Item 7.01 disclosure announces supplemental materials for a post-merger modeling call following Coursera's May 11, 2026 completion of its merger with Udemy. The filing provides financial outlook for 2026 on a combined basis, supplemental unaudited historical revenue data, and integration framework. While the merger itself (completed in May) would have been an ma_activity event, this June 23 filing is a post-close disclosure of supplemental modeling materials and forward guidance for the combined entity. The disclosure is operational in nature—providing investor context on integration, reporting framework, and business outlook—rather than announcing a new M&A transaction or other specific event type. The materiality is high given the scale of the combination and its impact on future performance expectations.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-23
EX-99.1
Vox Royalty completed the sale of the Federation Gold Royalty for A$8,000,000 in cash, representing a disposition of a material asset. The press release explicitly states "Vox Royalty sells Federation Gold Royalty" and describes the transaction as a completed divestment. While the company characterizes it as "opportunistic," the sale of a royalty interest constitutes a material disposition event requiring disclosure under M&A activity categories.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of New York. Schedule A lists multiple debt securities with trade dates in June 2026, settlement dates, maturity dates, and principal amounts totaling approximately $1.194 billion. This is a classic debt issuance disclosure under Item 2.03, creating new direct financial obligations for the Bank.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This 8-K Item 5.07 discloses the final voting results from Inuvo's June 18, 2026 Annual Meeting of Stockholders, including election of two Class III directors (Rob Buchner and Sanja Partalo) and ratification of EisnerAmper LLP as independent auditor. The filing presents tabulated vote counts (For, Withheld/Against, Abstained, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Exec departure
confidence 94%
filed 2026-06-23
Item 5.02
Ben M. Palmer, Director, President, and Chief Executive Officer of RPC, Inc., notified the Company on June 16, 2026 of his decision to retire effective on the earlier of a successor being named or December 31, 2026, ending a 30-year tenure with the company including 4 years as CEO.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-23
Item 5.02
This Item 5.02(e) disclosure describes grants of restricted stock units (RSUs) and performance-based restricted stock units (PBRSUs) to named executives including CEO J. Douglas Schick (22,830 RSUs + 15,220 PBRSUs), EVP/General Counsel Clark Moore (18,950 RSUs + 5,270 PBRSUs), Chief Commercial Officer Jody Crook (16,050 RSUs + 7,020 PBRSUs), and other employees, approved by the Compensation Committee as part of the 2025 annual compensation review. This is a classic compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Okta held its Annual Meeting of stockholders on June 18, 2026, with voting results on four proposals: election of two Class III directors (Anthony Bates and David Schellhase), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2017 Equity Incentive Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a clear disclosure of shareholder vote results from AdvanSix's Annual Meeting of Stockholders held on June 22, 2026, covering three matters: election of nine directors, ratification of PricewaterhouseCoopers LLP as independent accountants, and an advisory vote on executive compensation. The filing presents detailed voting tallies (For, Against, Abstain, and Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures. These outcomes are material to investors as they confirm the composition of the board and auditor selection.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
The filing discloses an unregistered sale of equity securities under Item 3.02, specifically the issuance of 179,051 shares of Series A Convertible Preferred Stock in a Rule 506(b) private placement during June 2026, generating $1.735 million in gross proceeds. This is a dilutive equity issuance to accredited investors that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-06-23
The 6-K discloses a Board-approved amendment to the Mynd.ai Equity Incentive Plan on June 17, 2026, increasing available shares by 106,000,000 Ordinary Shares. This is a material amendment to a compensatory arrangement affecting equity grants to directors, officers, and employees. The substantial one-time increase to the equity pool, combined with the existing evergreen provision, materially expands the Company's capacity to grant equity awards and would affect investor assessment of dilution and executive compensation practices.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
The filing discloses multiple unregistered sales of equity securities (Class E and Class I common shares) totaling approximately $3.15 million in aggregate consideration, issued pursuant to Section 4(a)(2) of the Securities Act. These include management fee payments to the Adviser (107,584 Class I shares), distribution reinvestment plan issuances to Brookfield affiliates (162,691 Class I shares and 23,894 Class E shares), and reinvestment plan issuances to a feeder vehicle for non-U.S. persons (9,344 Class I shares). The issuance of unregistered equity securities, particularly to related parties and in connection with management compensation and reinvestment programs, is material to investors as it dilutes existing shareholders and affects the capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This 8-K Item 5.07 discloses the results of Arlo Technologies' 2026 Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on three proposals: election of three Class II directors (Grady K. Summers, Prashant Aggarwal, and Amy Rothstein), ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. The filing presents final vote tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-23
Item 1.01
CIM Opportunity Zone Fund entered into a Financing Agreement on June 16, 2026, creating senior secured credit facilities totaling approximately $972.5 million (construction loan of $372.2M, bridge loan of $166.7M, term loan of $372.2M, and letter of credit facilities of $61.3M) to finance a 246.4 MWac solar facility and 150 MWac/600 MWh battery storage system in California, secured by substantially all assets of the borrower entities and guaranteed by the Sponsor.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 8.01
Robinhood announced the pricing of a $2.0 billion private offering of 0.00% convertible senior notes due 2029 in a Rule 144A transaction. This is a material creation of a direct financial obligation—a debt issuance—distinct from equity or other capital structures. The filing explicitly discloses the principal amount, maturity date, conversion terms, and use of proceeds, all hallmarks of a debt_issuance event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure presents the final voting results from Firy Inc.'s 2026 Annual Meeting of Stockholders held on June 18, 2026, including detailed vote tallies for three proposals: election of eight directors, ratification of Deloitte & Touche LLP as independent auditor, and approval of an amendment to the 2020 Omnibus Incentive Plan. The tabular presentation of votes for, against, abstentions, and broker non-votes is the standard format for shareholder vote result disclosures required by Item 5.07.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Item 3.02
Blackstone Private Credit Fund completed an unregistered sale of 278,469 Class I common shares for $6.67 million, exempt under Section 4(a)(2) and Regulation S, representing a private placement that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-23
Item 7.01
The Fund declared regular monthly distributions to shareholders across Class I, S, and D share classes for June and July 2026, with specified per-share amounts and payment dates.
View raw filing on EDGAR →